Musculoskeletal gene therapy and its potential use in the treatment of complicated musculoskeletal infection

Infectious Disease Clinics of North America

Volumn 19, Issue 4, 2005, Pages 1007-1022

  Shen, Wei ^a,b   Li, Yong ^a,c   Huard, Johnny ^a,b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIBIOTIC AGENT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 12; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLOPHOSPHAMIDE; DECORIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HLA G ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LENTIVIRUS VECTOR; MATRIX METALLOPROTEINASE; NUCLEIC ACID BINDING PROTEIN; OSTEOGENIC PROTEIN 1; PLASMID VECTOR; PLATELET DERIVED GROWTH FACTOR B; SMAD PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR L SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UTROPHIN;

ANTERIOR CRUCIATE LIGAMENT; BONE REMODELING; CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CHONDROGENESIS; DNA MODIFICATION; DUCHENNE MUSCULAR DYSTROPHY; EX VIVO STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSFECTION; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; IN VIVO STUDY; INFECTION; INFECTIOUS ARTHRITIS; KNEE MENISCUS; LONG TERM CARE; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSSIFICATION; OSTEOMYELITIS; PYOMYOSITIS; REACTIVE ARTHRITIS; REVIEW; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS AUREUS; STEM CELL GENE THERAPY; STREPTOCOCCUS PYOGENES; TISSUE REGENERATION; TISSUE REPAIR; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

BONE DISEASES; GENE THERAPY; HUMANS; MUSCULAR DISEASES;

EID: 27744567774     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2005.07.005     Document Type: Review

References (111)

1. D. Hannallah, B. Peterson, and J.R. Lieberman Gene therapy in orthopaedic surgery Instr Course Lect 52 2003 753 768
2. P.D. Robbins, and S.C. Ghivizani Viral vectors for gene therapy Pharmacol Ther 80 1998 35 47
3. C.H. Evans, and P.D. Robbins Possible orthopaedic applications of gene therapy J Bone Joint Surg Am 77 1995 1103 1114
4. J. Lisziewicz, D. Sun, and M. Klotman Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment Proc Natl Acad Sci U S A 89 1992 11209 11213
5. A. Gervaix, X. Li, and G. Kraus Multigene antiviral vectors inhibit diverse human immunodeficiency virus type 1 clades J Virol 71 1997 3048 3053
6. B.A. Sullenger, H.F. Gallardo, and G.E. Ungers Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication Cell 63 1990 601 608
7. B.A. Sullenger, H.F. Gallardo, and G.E. Ungers Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation J Virol 65 1991 6811 6816
8. I. Herskowitz Functional inactivation of genes by dominant negative mutations Nature 329 1987 219 222
9. L. Duan, O. Bagasra, and M.A. Laughlin Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody Proc Natl Acad Sci U S A 91 1994 5075 5079
10. D.C. Tang, M. DeVit, and S.A. Johnston Genetic immunization is a simple method for eliciting an immune response Nature 356 1992 152 154
11. J.B. Ulmer, J.J. Donnelly, and S.E. Parker Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259 1993 1745 1749
12. H.L. Davis, M.J. McCluskie, and J.L. Gerin DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines Proc Natl Acad Sci U S A 93 1996 7213 7218
13. H.E. Heslop, M.K. Brenner, and C. Rooney Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts Hum Gene Ther 5 1994 381 397
14. R.A. Morgan, and R. Walker Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins Hum Gene Ther 7 1996 1281 1306
15. R.E. Tascon, M.J. Colston, and S. Ragno Vaccination against tuberculosis by DNA injection Nat Med 2 1996 888 892
16. K. Tokushige, T. Wakita, and C. Pachuk Expression and immune response to hepatitis C virus core DNA-based vaccine constructs Hepatology 24 1996 14 20
17. E.A. Walter, P.D. Greenberg, and M.J. Gilbert Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1995 1038 1044
18. E. Manickan, Z. Yu, and R.J. Rouse Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27 Viral Immunol 8 1995 53 61
19. M. Christ, M. Lusky, and F. Stoeckel Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response Immunol Lett 57 1997 19 25
20. Y. Yang, F.A. Nunes, and K. Berencsi Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Proc Natl Acad Sci U S A 91 1994 4407 4411
21. Y. Okubo, K. Bessho, and K. Fujimura In vitro and in vivo studies of a bone morphogenetic protein-2 expressing adenoviral vector J Bone Joint Surg Am 83 Suppl 1, Pt 2 2001 S99 S104
22. Y. Okubo, K. Bessho, and K. Fujimura Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression Biochem Biophys Res Commun 267 2000 382 387
23. J. Bonadio, E. Smiley, and P. Patil Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration Nat Med 5 1999 753 759
24. A.W. Baltzer, C. Lattermann, and J.D. Whalen Potential role of direct adenoviral gene transfer in enhancing fracture repair Clin Orthop 379 2000 S120 S125
25. A.W. Baltzer, C. Lattermann, and J.D. Whalen Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene Gene Ther 7 2000 734 739
26. D.S. Musgrave, P. Bosch, and S. Ghivizzani Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone Bone 24 1999 541 547
27. J.R. Lieberman, A. Daluiski, and S. Stevenson The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats J Bone Joint Surg Am 81 1999 905 917
28. H. Peng, V. Wright, and A. Usas Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4 J Clin Invest 110 2002 751 759
29. J.L. Dragoo, J.Y. Choi, and J.R. Lieberman Bone induction by BMP-2 transduced stem cells derived from human fat J Orthop Res 21 2003 622 629
30. B. Peterson, J. Zhang, and R. Iglesias Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue Tissue Eng 11 2005 120 129
31. R.B. Rutherford, M. Moalli, and R.T. Franceschi Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo Tissue Eng 8 2002 441 452
32. K.R. Zaslav, and B.P. Meinhard Management of resistant pseudarthrosis of long bones Clin Orthop 233 1988 234 242
33. K.S. Albertson, R.J. Medoff, and M.M. Mitsunaga The use of periosteally vascularized autografts to augment the fixation of large segmental allografts Clin Orthop 269 1991 113 119
34. M. Bostrom, J.M. Lane, and E. Tomin Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model Clin Orthop 327 1996 272 282
35. L.L. Southwood, D.D. Frisbie, and C.E. Kawcak Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model J Orthop Res 22 2004 66 72
36. H.L. Moses, and R. Serra Regulation of differentiation by TGF-beta Curr Opin Genet Dev 6 1996 581 586
37. T. Izumi, S.P. Scully, and A. Heydemann Transforming growth factor beta 1 stimulates type II collagen expression in cultured periosteum-derived cells J Bone Miner Res 7 1992 115 121
38. R.S. Sellers, D. Peluso, and E.A. Morris The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage J Bone Joint Surg Am 79 1997 1452 1463
39. K. Sato, and M.R. Urist Bone morphogenetic protein-induced cartilage development in tissue culture Clin Orthop 183 1984 180 187
40. A.J. Nixon, R.A. Saxer, and B.D. Brower-Toland Exogenous insulin-like growth factor-I stimulates an autoinductive IGF-I autocrine/paracrine response in chondrocytes J Orthop Res 19 2001 26 32
41. L.A. Fortier, H.O. Mohammed, and G. Lust Insulin-like growth factor-I enhances cell-based repair of articular cartilage J Bone Joint Surg Br 84 2002 276 288
42. J.L. Ellsworth, J. Berry, and T. Bukowski Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors Osteoarthritis Cartilage 10 2002 308 320
43. K.D. Osborn, S.B. Trippel, and H.J. Mankin Growth factor stimulation of adult articular cartilage J Orthop Res 7 1989 35 42
44. M.K. Majumdar, E. Wang, and E.A. Morris BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1 J Cell Physiol 189 2001 275 284
45. B. de Crombrugghe, V. Lefebvre, and R.R. Behringer Transcriptional mechanisms of chondrocyte differentiation Matrix Biol 19 2000 389 394
46. H. Watanabe, M.P. de Caestecker, and Y. Yamada Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells J Biol Chem 276 2001 14466 14473
47. M. Osaki, T. Tsukazaki, and N. Ono cDNA cloning and chromosomal mapping of rat Smad2 and Smad4 and their expression in cultured rat articular chondrocytes Endocr J 46 1999 695 701
48. W.P. Arend Physiology of cytokine pathways in rheumatoid arthritis Arthritis Rheum 45 2001 101 106
49. S.C. Ghivizzani, E.R. Lechman, and R. Kang Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects Proc Natl Acad Sci U S A 95 1998 4613 4618
50. B.J. Roessler, E.D. Allen, and J.M. Wilson Adenoviral-mediated gene transfer to rabbit synovium in vivo J Clin Invest 92 2 1993 1085 1092
51. E. Gouze, R. Pawliuk, and J.N. Gouze Lentiviral-mediated gene delivery to synovium: potent intra-articular expression with amplification by inflammation Mol Ther 7 2003 460 466
52. E. Gouze, R. Pawliuk, and C. Pilapil In vivo gene delivery to synovium by lentiviral vectors Mol Ther 5 2002 397 404
53. Z. Mi, S.C. Ghivizzani, and E.R. Lechman Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints Arthritis Rheum 43 2000 2563 2570
54. R.A. Saxer, S.J. Bent, and B.D. Brower-Toland Gene mediated insulin-like growth factor-I delivery to the synovium J Orthop Res 19 2001 759 767
55. Z. Mi, S.C. Ghivizzani, and E. Lechman Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees Arthritis Res Ther 5 2003 R132 R139
56. R. Kang, T. Marui, and S.C. Ghivizzani Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study Osteoarthritis Cartilage 5 1997 139 143
57. F.D. Shuler, H.I. Georgescu, and C. Niyibizi Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes J Orthop Res 18 2000 585 592
58. P. Smith, F.D. Shuler, and H.I. Georgescu Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1 Arthritis Rheum 43 2000 1156 1164
59. A.J. Nixon, B.D. Brower-Toland, and S.J. Bent Insulinlike growth factor-I gene therapy applications for cartilage repair Clin Orthop 379 2000 S201 S213
60. C. Hidaka, M. Quitoriano, and R.F. Warren Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7 J Orthop Res 19 2001 751 758
61. M. Ahrens, T. Ankenbauer, and D. Schroder Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages DNA Cell Biol 12 1993 871 880
62. G. Turgeman, D.D. Pittman, and R. Muller Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy J Gene Med 3 2001 240 251
63. F.A. van de Loo, A.S. de Hooge, and R.L. Smeets An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint Gene Ther 11 2004 581 590
64. A.A. van de Loo, O.J. Arntz, and A.C. Bakker Role of interleukin 1 in antigen-induced exacerbations of murine arthritis Am J Pathol 146 1995 239 249
65. F.A. van de Loo, L.A. Joosten, and P.L. van Lent Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen- and zymosan-induced arthritis Arthritis Rheum 38 1995 164 172
66. X.Y. Song, M. Gu, and W.W. Jin Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model J Clin Invest 101 1998 2615 2621
67. C. Bloquel, N. Bessis, and M.C. Boissier Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants Hum Gene Ther 15 2004 189 201
68. E. Parks, R.M. Strieter, and N.W. Lukacs Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis J Immunol 160 1998 4615 4619
69. Y. Kageyama, Y. Koide, and M. Uchijima Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis Arthritis Rheum 50 2004 968 975
70. N. Nakamura, S. Horibe, and N. Matsumoto Transient introduction of a foreign gene into healing rat patellar ligament J Clin Invest 97 1996 226 231
71. I. Ozkan, K. Shino, and N. Nakamura Direct in vivo gene transfer to healing rat patellar ligament by intra-arterial delivery of haemagglutinating virus of Japan liposomes Eur J Clin Invest 29 1999 63 67
72. R.S. Goomer, T.M. Maris, and R. Gelberman Nonviral in vivo gene therapy for tissue engineering of articular cartilage and tendon repair Clin Orthop 379 2000 S189 S200
73. J. Lou, Y. Tu, and M. Burns BMP-12 gene transfer augmentation of lacerated tendon repair J Orthop Res 19 2001 1199 1202
74. Q. Dai, L. Manfield, and Y. Wang Adenovirus-mediated gene transfer to healing tendon-enhanced efficiency using a gelatin sponge J Orthop Res 21 2003 604 609
75. K.A. Hildebrand, M. Deie, and C.R. Allen Early expression of marker genes in the rabbit medial collateral and anterior cruciate ligaments: the use of different viral vectors and the effects of injury J Orthop Res 17 1999 37 42
76. N. Nakamura, S.A. Timmermann, and D.A. Hart A comparison of in vivo gene delivery methods for antisense therapy in ligament healing Gene Ther 5 1998 1455 1461
77. J. Menetrey, C. Kasemkijwattana, and C.S. Day Direct-, fibroblast- and myoblast-mediated gene transfer to the anterior cruciate ligament Tissue Eng 5 1999 435 442
78. J. Lou, P.R. Manske, and M. Aoki Adenovirus-mediated gene transfer into tendon and tendon sheath J Orthop Res 14 1996 513 517
79. J. Lou, H. Kubota, and S. Hotokezaka In vivo gene transfer and overexpression of focal adhesion kinase (pp125 FAK) mediated by recombinant adenovirus-induced tendon adhesion formation and epitenon cell change J Orthop Res 15 1997 911 918
80. N. Nakamura, K. Shino, and T. Natsuume Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament Gene Ther 5 1998 1165 1170
81. N. Nakamura, D.A. Hart, and R.S. Boorman Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo J Orthop Res 18 2000 517 523
82. D.A. Hart, N. Nakamura, and L. Marchuk Complexity of determining cause and effect in vivo after antisense gene therapy Clin Orthop 379 2000 S242 S251
83. J.J. Canoso, and M. Barza Soft tissue infections Rheum Dis Clin North Am 19 1993 293 309
84. R.B. Jeffrey Jr., F.C. Laing, and W.P. Schechter Acute suppurative tenosynovitis of the hand: diagnosis with US Radiology 162 1987 741 742
85. C. Kasemkijwattana, J. Menetrey, and P. Bosch Use of growth factors to improve muscle healing after strain injury Clin Orthop 370 2000 272 285
86. J. Menetrey, C. Kasemkijwattana, and C.S. Day Growth factors improve muscle healing in vivo J Bone Joint Surg Br 82 2000 131 137
87. C.W. Lee, K. Fukushima, and A. Usas Biological intervention based on cell and genetherapy to improve muscle healing after laceration J Musculoskel Res 4 2000 265 277
88. E.R. Barton-Davis, D.I. Shoturma, and A. Musaro Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function Proc Natl Acad Sci U S A 95 1998 15603 15607
89. P.D. Yurchenco Assembly of basement membranes Ann N Y Acad Sci 580 1990 195 213
90. J. Huard, W.G. Feero, and S.C. Watkins The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers J Virol 70 1996 8117 8123
91. R. Pruchnic, B. Cao, and Z.Q. Peterson The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers Hum Gene Ther 11 2000 521 536
92. Z. Wang, T. Zhu, and C. Qiao Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart Nat Biotechnol 23 2005 321 328
93. A.P. Brooks, and A.E. Emery The incidence of Duchenne muscular dystrophy in the South East of Scotland Clin Genet 11 1977 290 294
94. A.J. van Essen, H.F. Busch, and G.J. te Meerman Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands Hum Genet 88 1992 258 266
95. S.E. Tangsrud, and S. Halvorsen Child neuromuscular disease in southern Norway: the prevalence and incidence of Duchenne muscular dystrophy Acta Paediatr Scand 78 1989 100 103
96. S. Kochanek, P.R. Clemens, and K. Mitani A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase Proc Natl Acad Sci U S A 93 1996 5731 5736
97. H.H. Chen, L.M. Mack, and R. Kelly Persistence in muscle of an adenoviral vector that lacks all viral genes Proc Natl Acad Sci U S A 94 1997 1645 1650
98. G.R. Akkaraju, J. Huard, and E.P. Hoffman Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle J Gene Med 1 1999 280 289
99. J. Huard, D. Krisky, and T. Oligino Gene transfer to muscle using herpes simplex virus-based vectors Neuromuscul Disord 7 1997 299 313
100. S.Q. Harper, M.A. Hauser, and C. DelloRusso Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy Nat Med 8 2002 253 261
101. J. Watchko, T. O'Day, and B. Wang Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice Hum Gene Ther 13 2002 1451 1460
102. L.E. Warner, C. DelloRusso, and R.W. Crawford Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy Hum Mol Genet 11 2002 1095 1105
103. G.E. Crawford, J.A. Faulkner, and R.H. Crosbie Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain J Cell Biol 150 2000 1399 1410
104. K. Yuasa, Y. Miyagoe, and K. Yamamoto Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs FEBS Lett 425 1998 329 336
105. J.M. Tinsley, D.J. Blake, and A. Roche Primary structure of dystrophin-related protein Nature 360 1992 591 593
106. J. Tinsley, N. Deconinck, and R. Fisher Expression of full-length utrophin prevents muscular dystrophy in mdx mice Nat Med 4 1998 1441 1444
107. K.J. Perkins, E.A. Burton, and K.E. Davies The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy Nucleic Acids Res 29 2001 4843 4850
108. Y. Mizuno, I. Nonaka, and S. Hirai Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects J Neurol Sci 119 1993 43 52
109. I. Lundberg, A.K. Ulfgren, and P. Nyberg Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies Arthritis Rheum 40 1997 865 874
110. I.E. Lundberg The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies Curr Rheumatol Rep 2 2000 216 224
111. H. Wiendl, M. Mitsdoerffer, and V. Hofmeister The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy Brain 126 pt 1 2003 176 185